Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $3,740 | 2 | 53.1% |
| Travel and Lodging | $1,776 | 5 | 25.2% |
| Honoraria | $1,200 | 2 | 17.0% |
| Food and Beverage | $190.72 | 3 | 2.7% |
| Unspecified | $143.00 | 1 | 2.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| TOLMAR Pharmaceuticals, Inc. | $5,524 | 8 | $0 (2022) |
| Tolmar, Inc. | $1,358 | 3 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $143.00 | 1 | $0 (2020) |
| Abbott Laboratories | $24.65 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $1,358 | 3 | Tolmar, Inc. ($1,358) |
| 2022 | $5,524 | 8 | TOLMAR Pharmaceuticals, Inc. ($5,524) |
| 2020 | $143.00 | 1 | Novartis Pharmaceuticals Corporation ($143.00) |
| 2018 | $24.65 | 1 | Abbott Laboratories ($24.65) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/07/2023 | Tolmar, Inc. | FENSOLVI (Drug) | Honoraria | Cash or cash equivalent | $400.00 | General |
| Category: Central Precocious Puberty (CPP) | ||||||
| 07/13/2023 | Tolmar, Inc. | FENSOLVI (Drug) | Honoraria | Cash or cash equivalent | $800.00 | General |
| Category: Central Precocious Puberty (CPP) | ||||||
| 06/14/2023 | Tolmar, Inc. | ELIGARD (Drug) | Food and Beverage | In-kind items and services | $158.35 | General |
| Category: Prostate Cancer | ||||||
| 09/15/2022 | TOLMAR Pharmaceuticals, Inc. | FENSOLVI (Drug) | Consulting Fee | Cash or cash equivalent | $680.00 | General |
| Category: Central Precocious Puberty (CPP) | ||||||
| 07/14/2022 | TOLMAR Pharmaceuticals, Inc. | FENSOLVI (Drug) | Consulting Fee | Cash or cash equivalent | $3,060.00 | General |
| Category: Central Precocious Puberty (CPP) | ||||||
| 07/14/2022 | TOLMAR Pharmaceuticals, Inc. | FENSOLVI (Drug) | Travel and Lodging | Cash or cash equivalent | $777.21 | General |
| Category: Central Precocious Puberty (CPP) | ||||||
| 07/14/2022 | TOLMAR Pharmaceuticals, Inc. | FENSOLVI (Drug) | Travel and Lodging | Cash or cash equivalent | $459.00 | General |
| Category: Central Precocious Puberty (CPP) | ||||||
| 07/14/2022 | TOLMAR Pharmaceuticals, Inc. | FENSOLVI (Drug) | Travel and Lodging | Cash or cash equivalent | $269.90 | General |
| Category: Central Precocious Puberty (CPP) | ||||||
| 06/20/2022 | TOLMAR Pharmaceuticals, Inc. | FENSOLVI (Drug) | Travel and Lodging | Cash or cash equivalent | $134.95 | General |
| Category: Central Precocious Puberty (CPP) | ||||||
| 06/16/2022 | TOLMAR Pharmaceuticals, Inc. | FENSOLVI (Drug) | Travel and Lodging | Cash or cash equivalent | $134.95 | General |
| Category: Central Precocious Puberty (CPP) | ||||||
| 06/11/2022 | TOLMAR Pharmaceuticals, Inc. | FENSOLVI (Drug) | Food and Beverage | In-kind items and services | $7.72 | General |
| Category: Central Precocious Puberty (CPP) | ||||||
| 03/01/2020 | Novartis Pharmaceuticals Corporation | TASIGNA (Drug) | — | In-kind items and services | $143.00 | Research |
| Study: RESEARCH RELATED PUBLICATIONS SUPPORT • Category: HEMATOLOGY | ||||||
| 02/20/2018 | Abbott Laboratories | FreeStyle Lite system (Device) | Food and Beverage | In-kind items and services | $24.65 | General |
| Category: Diabetes Care | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| RESEARCH RELATED PUBLICATIONS SUPPORT | Novartis Pharmaceuticals Corporation | $143.00 | 1 |
About Dr. Jill Samis, MD
Dr. Jill Samis, MD is a Pediatrics healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/04/2008. The National Provider Identifier (NPI) number assigned to this provider is 1356507842.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jill Samis, MD has received a total of $7,050 in payments from pharmaceutical and medical device companies, with $1,358 received in 2023. These payments were reported across 13 transactions from 4 companies. The most common payment nature is "Consulting Fee" ($3,740).
Practice Information
- Specialty Pediatrics
- Other Specialties Pediatric Endocrinology
- Location Chicago, IL
- Active Since 08/04/2008
- Last Updated 02/23/2024
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1356507842
Products in Payments
- FENSOLVI (Drug) $6,724
- ELIGARD (Drug) $158.35
- TASIGNA (Drug) $143.00
- FreeStyle Lite system (Device) $24.65
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Chicago
Mrs. Amy Paller, Md, MD
Pediatrics — Payments: $1.7M
Jan Berger, Md, MD
Pediatrics — Payments: $689,585
Anita Chandra-Puri
Pediatrics — Payments: $338,928
Mindy Simpson, M.d, M.D
Pediatrics — Payments: $310,808
Dr. Amanda Salih, Md, Mph, MD, MPH
Pediatrics — Payments: $160,245
Dr. Patricia Chiamas, M.d, M.D
Pediatrics — Payments: $143,199